Biological Identity of Nanoparticles In Vivo : Clinical Implications of the Protein Corona

Despite the advances in biomedical applications of nanoparticle (NP) and numerous publications, few NPs have made it to clinical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of our limited understanding of t...

Full description

Saved in:
Bibliographic Details
Published inTrends in biotechnology (Regular ed.) Vol. 35; no. 3; pp. 257 - 264
Main Authors Caracciolo, Giulio, Farokhzad, Omid C, Mahmoudi, Morteza
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.03.2017
Elsevier Limited
Subjects
Adsorption
Animals
Associations
biological identity
Biomedical Research
Humans
Internal Medicine
Mice
nanobio interfaces
Nanomaterials
Nanoparticles
Physiology
Polyethylene glycol
Protein Corona
Proteins
Researchers
Shear stress
nanobio interfaces
nanoparticles
biological identity
protein corona
Online AccessGet full text

Cover

More Information
Summary:Despite the advances in biomedical applications of nanoparticle (NP) and numerous publications, few NPs have made it to clinical trials and even fewer have reached clinical practice. This wide gap between bench discoveries and clinical applications is mainly because of our limited understanding of the biological identity of NPs. In physiological environments, NPs are coated by a ‘protein corona’ (PC), critically affecting physiological and therapeutic responses. To date, nearly all studies attempting to characterize the PC have been conducted in vitro . Here, we review recent advances in our understanding of the in vivo PC. We also discuss recent developments of quantitative models to predict biological interactions and how they offer new opportunities for the clinical translation of NPs.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0167-7799
1879-3096
DOI:10.1016/j.tibtech.2016.08.011